Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002048956-24-000001·Adverum Biotechnologies, Inc.
Schedule 13G ownership disclosure
ADVERUM BIOTECHNOLOGIES INC
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 · CUSIP: 00773U207
Event date: 2024-12-17
- Filing-level shares
- 1,050,000.00
- Percent of class
- 5.1%
- Rush Ryan Bradford
Shares: 1,050,000.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002048956-24-000001
- Form type
- SCHEDULE 13G
- Filer
- Adverum Biotechnologies, Inc.
- CIK
- CIK 1501756
- Filed
- Dec 17, 2024
- Reporting period
- Dec 17, 2024
- Description
- Schedule 13G beneficial ownership